FDA Approves Self-Administered Nasal Flu Vaccine for U.S. Consumers
The FDA has approved the first nasal spray flu vaccine for self-administration, offering a needle-free, convenient option as the U.S. prepares for the upcoming flu season.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
The FDA has approved the first nasal spray flu vaccine for self-administration, offering a needle-free, convenient option as the U.S. prepares for the upcoming flu season.
Africa CDC and WHO launch a $600 million response plan to address the rising mpox cases across the continent, focusing on the DRC epicenter.
China’s State Council Information Office invites leading health professionals to a press meeting, fostering open dialogue and enhancing public trust through transparent communication.
WHO assures mpox is not the new COVID-19, emphasizing that existing control measures are effective in managing its spread globally.
Japan’s heatwave in July 2024 led to a 20% increase in heatstroke cases, marking the second-highest number since 2008, with sweltering temperatures claiming 62 lives.
African scientists warn of a troubling increase in mosquito-borne diseases like malaria and dengue fever, exacerbated by climate change and impacting public health and economic growth.
Norway and the Netherlands heighten alert for a new mpox variant after Sweden’s first Clade I case, ensuring robust health preparedness and vaccine availability.
WHO declares mpox a public health emergency, highlighting rising cases and the risk of further spread. The EU and biotech firms are responding with vaccine donations.
Spain has reported three heat-related deaths as a record-breaking heat wave continues to affect the country, causing widespread extreme temperatures.
The WHO’s emergency committee meets on August 14 to assess the Mpox outbreak in Africa and decide on potential global health measures.